180 related articles for article (PubMed ID: 30943748)
1. LncRNA SNHG20 promotes tumorigenesis and cancer stemness in glioblastoma via activating PI3K/Akt/mTOR signaling pathway.
Gao XF; He HQ; Zhu XB; Xie SL; Cao Y
Neoplasma; 2019 Jul; 66(4):532-542. PubMed ID: 30943748
[TBL] [Abstract][Full Text] [Related]
2. Influences of LncRNA SNHG20 on proliferation and apoptosis of glioma cells through regulating the PTEN/PI3K/AKT signaling pathway.
Guo LP; Zhang ZJ; Li RT; Li HY; Cui YQ
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):253-261. PubMed ID: 30657567
[TBL] [Abstract][Full Text] [Related]
3. LncRNA TP73-AS1 Promotes Cell Proliferation and Inhibits Cell Apoptosis in Clear Cell Renal Cell Carcinoma Through Repressing KISS1 Expression and Inactivation of PI3K/Akt/mTOR Signaling Pathway.
Liu G; Zhao X; Zhou J; Cheng X; Ye Z; Ji Z
Cell Physiol Biochem; 2018; 48(1):371-384. PubMed ID: 30016766
[TBL] [Abstract][Full Text] [Related]
4. LncRNA AB073614 regulates proliferation and metastasis of colorectal cancer cells via the PI3K/AKT signaling pathway.
Wang Y; Kuang H; Xue J; Liao L; Yin F; Zhou X
Biomed Pharmacother; 2017 Sep; 93():1230-1237. PubMed ID: 28738539
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of long non-coding RNA SNHG20 promotes ovarian cancer progression via Wnt/β-catenin signaling.
He S; Zhao Y; Wang X; Deng Y; Wan Z; Yao S; Shen H
Biosci Rep; 2018 Feb; 38(1):. PubMed ID: 29101241
[TBL] [Abstract][Full Text] [Related]
6. LncRNA SNHG20 promotes cell proliferation and invasion via miR-140-5p-ADAM10 axis in cervical cancer.
Guo H; Yang S; Li S; Yan M; Li L; Zhang H
Biomed Pharmacother; 2018 Jun; 102():749-757. PubMed ID: 29604594
[TBL] [Abstract][Full Text] [Related]
7. LncRNA SNHG20 promoted the proliferation of glioma cells via sponging miR-4486 to regulate the MDM2-p53 pathway.
Liu J; Cheng LG; Li HG
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5323-5331. PubMed ID: 31298384
[TBL] [Abstract][Full Text] [Related]
8. LncRNA ENST00113 promotes proliferation, survival, and migration by activating PI3K/Akt/mTOR signaling pathway in atherosclerosis.
Yao X; Yan C; Zhang L; Li Y; Wan Q
Medicine (Baltimore); 2018 Apr; 97(16):e0473. PubMed ID: 29668625
[TBL] [Abstract][Full Text] [Related]
9. SNHG20 knockdown suppresses proliferation, migration and invasion, and promotes apoptosis in non-small cell lung cancer through acting as a miR-154 sponge.
Lingling J; Xiangao J; Guiqing H; Jichan S; Feifei S; Haiyan Z
Biomed Pharmacother; 2019 Apr; 112():108648. PubMed ID: 30780105
[TBL] [Abstract][Full Text] [Related]
10. LncRNA SAMMSON Knockdown Inhibits the Malignancy of Glioblastoma Cells by Inactivation of the PI3K/Akt Pathway.
Ni H; Wang K; Xie P; Zuo J; Liu W; Liu C
Cell Mol Neurobiol; 2021 Jan; 41(1):79-90. PubMed ID: 32236901
[TBL] [Abstract][Full Text] [Related]
11. Long Non-Coding RNA XLOC_006753 Promotes the Development of Multidrug Resistance in Gastric Cancer Cells Through the PI3K/AKT/mTOR Signaling Pathway.
Zeng L; Liao Q; Zou Z; Wen Y; Wang J; Liu C; He Q; Weng N; Zeng J; Tang H; Fang R; Lei Z; Tang Z; Yang X; Cui S
Cell Physiol Biochem; 2018; 51(3):1221-1236. PubMed ID: 30481766
[TBL] [Abstract][Full Text] [Related]
12. LINC00968 functions as an oncogene in osteosarcoma by activating the PI3K/AKT/mTOR signaling.
Liu G; Yuan D; Sun P; Liu W; Wu PF; Liu H; Yu GY
J Cell Physiol; 2018 Nov; 233(11):8639-8647. PubMed ID: 29904919
[TBL] [Abstract][Full Text] [Related]
13. C-MYC-activated lncRNA SNHG20 accelerates the proliferation of diffuse large B cell lymphoma via USP14-mediated deubiquitination of β-catenin.
Wang C; Fu W; Zhang Y; Hu X; Xu Q; Tong X
Biol Direct; 2024 Jun; 19(1):47. PubMed ID: 38886753
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA SNHG20 promotes bladder cancer via activating the Wnt/β-catenin signalling pathway.
Zhao Q; Gao S; Du Q; Liu Y
Int J Mol Med; 2018 Nov; 42(5):2839-2848. PubMed ID: 30106094
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of lncRNA OGFRP1 Inhibits Proliferation and Invasion of JEG-3 Cells Via AKT/mTOR Pathway.
Meng Q; Xue H
Technol Cancer Res Treat; 2020; 19():1533033820905823. PubMed ID: 32233835
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA SNHG20 promotes the tumorigenesis of oral squamous cell carcinoma via targeting miR-197/LIN28 axis.
Wu J; Zhao W; Wang Z; Xiang X; Zhang S; Liu L
J Cell Mol Med; 2019 Jan; 23(1):680-688. PubMed ID: 30394668
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA SNHG20 predicts a poor prognosis for HCC and promotes cell invasion by regulating the epithelial-to-mesenchymal transition.
Liu J; Lu C; Xiao M; Jiang F; Qu L; Ni R
Biomed Pharmacother; 2017 May; 89():857-863. PubMed ID: 28282787
[TBL] [Abstract][Full Text] [Related]
18. Expression of Long Nonencoding Ribonucleic Acid SNHG20 in Colon Cancer Tissue in Its Influences on Chemotherapeutic Sensitivity of Colon Cancer Cells.
Cao W; Zhang B; Liu Y
Biomed Res Int; 2022; 2022():4752782. PubMed ID: 35915794
[TBL] [Abstract][Full Text] [Related]
19. LncRNA SNHG20 knockdown suppresses the osteosarcoma tumorigenesis through the mitochondrial apoptosis pathway by miR-139/RUNX2 axis.
Wang W; Luo P; Guo W; Shi Y; Xu D; Zheng H; Jia L
Biochem Biophys Res Commun; 2018 Sep; 503(3):1927-1933. PubMed ID: 30072099
[TBL] [Abstract][Full Text] [Related]
20. Increased long noncoding RNA SNHG20 predicts poor prognosis in colorectal cancer.
Li C; Zhou L; He J; Fang XQ; Zhu SW; Xiong MM
BMC Cancer; 2016 Aug; 16():655. PubMed ID: 27543107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]